Somewhat Positive Media Coverage Somewhat Unlikely to Affect R1 RCM (RCM) Stock Price

News coverage about R1 RCM (NASDAQ:RCM) has trended somewhat positive on Tuesday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. R1 RCM earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.9365467102059 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

A number of brokerages have recently issued reports on RCM. BidaskClub upgraded shares of R1 RCM from a “hold” rating to a “buy” rating in a report on Thursday, January 11th. Zacks Investment Research cut shares of R1 RCM from a “hold” rating to a “sell” rating in a research note on Wednesday, January 17th.

Shares of R1 RCM (RCM) remained flat at $$4.75 during midday trading on Tuesday. 52,127 shares of the stock were exchanged, compared to its average volume of 196,998. The stock has a market capitalization of $515.55, a price-to-earnings ratio of -18.27 and a beta of -0.41. R1 RCM has a twelve month low of $2.02 and a twelve month high of $5.43.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Insider Buying and Selling by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with's FREE daily email newsletter.

Leave a Reply